This is the "Home" page of the "Prospective Clinical Trials Involving the Consent Process" guide.
Alternate Page for Screenreader Users
Skip to Page Navigation
Skip to Page Content

Prospective Clinical Trials Involving the Consent Process  

Last Updated: Feb 1, 2017 URL: Print Guide RSS UpdatesEmail Alerts

Home Print Page


The Human Research Protection Program provides these templates and tools to promote increased adherence with Federal, State, and Institution Policy.  Baystate voluntarily applies the International Conference on Harmonization (“ICH”) Good Clinical Practices (“GCP”) Guidelines (sometimes referred to as “ICH-GCP” or E6) to the extent they are compatible with FDA and DHHS regulations. 

Creating your regulatory folder/binder: 

Create tabs for each section listed above and place the appropriate documents in each corresponding section in a binder.  Be sure to label the outside of the binder (cover and spine) with the protocol number, PI name, and study site.  Use multiple or master binders to maintain documentation if necessary.

All Baystate Health System human subject research studies are subject to routine audits by the Human Research Protection Program and may also be reviewed by external entities such as the study sponsor or government agencies.

Often sponsors will provide a regulatory binder.  When a sponsor provides a binder it may be lacking one or more of the sections identified in this document.  The investigator is responsible for ensuring all sections identified in this document not provided by the sponsor are added to the binder.


    baystate health sciences library 759 Chestnut St., Springfield, MA 01199
    tel: 413.794.1865 | fax: 413.794.1974 | contact us

    Last reviewed/updated on June 25, 2012


    Loading  Loading...